Olcare Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1.50%
(FY 2023)
- Profit 21.63%
(FY 2023)
- Ebitda 19.99%
(FY 2023)
- Net Worth 37.47%
(FY 2023)
- Total Assets 3.65%
(FY 2023)
About Olcare Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arunaben Mehta, Dhwani Mehta, and Kruti Mehta serve as directors at the Company.
- CIN/LLPIN
U24299GJ2018PTC100958
- Company No.
100958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surendra Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Olcare Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kruti Mehta  | Director | 23-Feb-2018 | Current |
| Arunaben Mehta | Director | 23-Feb-2018 | Current |
| Dhwani Mehta | Director | 23-Feb-2018 | Current |
Financial Performance of Olcare Laboratories.
Olcare Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.5% increase. The company also saw a substantial improvement in profitability, with a 21.63% increase in profit. The company's net worth Soared by an impressive increase of 37.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olcare Laboratories?
In 2023, Olcare Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Carol Laboratories Private LimitedActive 29 years 4 monthsArunaben Mehta, Dhwani Mehta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Olcare Laboratories?
Olcare Laboratories has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olcare Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olcare Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
